A phase II study to evaluate safety and efficacy of neoadjuvant pembrolizumab and radiotherapy in localized MSS rectal cancer

被引：0
|
作者：
Kossler, Thibaud
Nicolas, Buchs
Dutoit, Valerie
Puppa, Giacomo
Tsantoulis, Petros
Frossard, Jean-Louis
Bichard, Philippe
Montet, Xavier
Mckee, Thomas
Di Marco, Mariagrazia
Dietrich, Pierre-Yves
Roth, Arnaud
Zilli, Thomas
Ris, Frederic
机构：
[1] Geneva Univ Hosp, Geneva, Switzerland
[2] Geneva Univ Hosp, Ctr Oncol, Geneva, Switzerland
[3] Hop Univ Geneve, Geneva 14, Switzerland
[4] Univ Hosp Geneva, Geneva, Switzerland
[5] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS272
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PHASE II TRIAL OF NEOADJUVANT BEVACIZUMAB, CAPECITABINE, AND RADIOTHERAPY FOR LOCALLY ADVANCED RECTAL CANCER
    Crane, Christopher H.
    Eng, Cathy
    Feig, Barry W.
    Das, Prajnan
    Skibber, John M.
    Chang, George J.
    Wolff, Robert A.
    Krishnan, Sunil
    Hamilton, Stanley
    Janjan, Nora A.
    Maru, Dipen M.
    Ellis, Lee M.
    Rodriguez-Bigas, Miguel A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 824 - 830
  • [22] A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer
    Hasegawa, Suguru
    Goto, Saori
    Matsumoto, Takuya
    Hida, Koya
    Kawada, Kenji
    Matsusue, Ryo
    Yamaguchi, Takashi
    Nishitai, Ryuta
    Manaka, Dai
    Kato, Shigeru
    Kadokawa, Yoshio
    Yamanokuchi, Satoshi
    Kawamura, Junichiro
    Zaima, Masazumi
    Kyogoku, Takahisa
    Kanazawa, Akiyoshi
    Mori, Yukiko
    Kanai, Masashi
    Matsumoto, Shigemi
    Sakai, Yoshiharu
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (12) : 3587 - 3595
  • [23] A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal Cancer
    Suguru Hasegawa
    Saori Goto
    Takuya Matsumoto
    Koya Hida
    Kenji Kawada
    Ryo Matsusue
    Takashi Yamaguchi
    Ryuta Nishitai
    Dai Manaka
    Shigeru Kato
    Yoshio Kadokawa
    Satoshi Yamanokuchi
    Junichiro Kawamura
    Masazumi Zaima
    Takahisa Kyogoku
    Akiyoshi Kanazawa
    Yukiko Mori
    Masashi Kanai
    Shigemi Matsumoto
    Yoshiharu Sakai
    Annals of Surgical Oncology, 2017, 24 : 3587 - 3595
  • [24] Efficacy of Combined Pembrolizumab and Pelvic Radiotherapy for Bladder Cancer With Rectal Metastases
    Nagahisa, Chika
    Iizuka, Junpei
    Kobari, Yuki
    Minoda, Ryo
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Okuda, Hisashi
    Ishida, Hideki
    Nagashima, Yoji
    Takagi, Toshio
    IN VIVO, 2023, 37 (02): : 912 - 915
  • [25] A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.
    Goto, Saori
    Hasegawa, Suguru
    Matsumoto, Takuya
    Hida, Koya
    Kawamura, Junichiro
    Yamanokuchi, Satoshi
    Yamaguchi, Takashi
    Matsusue, Ryo
    Kadokawa, Yoshio
    Kato, Shigeru
    Manaka, Dai
    Nishitai, Ryuta
    Nomura, Akinari
    Kanazawa, Akiyoshi
    Kawada, Kenji
    Kyogoku, Takahisa
    Sakai, Yoshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [26] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    Angiogenesis, 2012, 15 : 141 - 150
  • [27] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    ANGIOGENESIS, 2012, 15 (01) : 141 - 150
  • [28] A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
    Velenik, V.
    Ocvirk, J.
    Oblak, I.
    Anderluh, F.
    EJSO, 2010, 36 (03): : 244 - 250
  • [29] A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer
    Zhao, Lin
    Bai, Chunmei
    Shao, Yajuan
    Guan, Mei
    Jia, Ning
    Xiao, Yi
    Qiu, Huizhong
    Zhang, Fuquan
    Yang, Ti
    Zhong, Guangxi
    Chen, Shuchang
    CANCER LETTERS, 2011, 310 (02) : 134 - 139
  • [30] Phase Ib/II study to evaluate safety and tolerability of cabiralizumab in combination with nivolumab and neoadjuvant chemotherapy in patients with localized triple-negative breast cancer
    Davis, Andrew A.
    Hernandez-Aya, Leonel
    Luo, Jingqin
    Opyrchal, Mateusz
    Ademuyiwa, Foluso O.
    Bagegni, Nusayba A.
    Clifton, Katherine K.
    Anderson, Jill
    Hammerschmidt, Trish
    Nehring, Leslie
    DeNardo, David
    Watson, Mark
    Aft, Rebecca
    Ma, Cynthia
    Weilbaecher, Katherine
    CANCER RESEARCH, 2023, 83 (05)
12345